Concord Biotech Limited (NSE:CONCORDBIO)

India · Delayed Price · Currency is INR

1,148.90

+3.30 (0.29%)

Feb 18, 2026, 3:15 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Manufacturing and trading in pharmaceutical products	12.00B	10.17B	8.53B	7.13B	6.17B
Manufacturing and trading in pharmaceutical products Growth	18.01%	19.20%	19.67%	15.56%	20.42%
Total	12.00B	10.17B	8.53B	7.13B	6.17B
Total Growth	18.01%	19.20%	19.67%	15.56%	20.42%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
India	6.62B	5.34B	4.32B	3.39B	2.53B
India Growth	23.89%	23.62%	27.40%	34.25%	-3.41%
America	1.38B	1.08B	1.47B	1.31B	1.60B
America Growth	27.77%	-26.67%	12.02%	-17.74%	100.23%
Others	4.00B	3.75B	2.74B	2.42B	2.04B
Others Growth	6.81%	36.88%	13.00%	18.48%	19.62%
Total	12.00B	10.17B	8.53B	7.13B	6.17B
Total Growth	18.01%	19.20%	19.67%	15.56%	20.42%

Source: S&P Global Market Intelligence.